Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
—
67.60%
80%
—
—
20%
—
5 Years
Score—
Net Growth67.60%
Net Trend80%
Net Income Consistency—
Rev Growth—
Rev Trend20%
Revenue Consistency—
Brainstorm Cell Therapeutics Inc fundamental performance
Across Brainstorm Cell Therapeutics Inc's full reported history, from 2003 to 2025, net income went from -$ 73.3K to -$ 10M. Revenue increased in 14% of the years measured; net income in 50%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.88 | — |
1 Year2025-08-12 | $ 0.63 | 39.68% |
5 Years2021-08-12 | $ 56.70 | -98.45% |
10 Years2016-08-12 | $ 35.55 | -97.52% |
20 Years2006-08-11 | $ 76.50 | -98.85% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 |
|---|---|---|---|---|---|
| Price | $ 0.88 | $ 0.63 | $ 56.70 | $ 35.55 | $ 76.50 |
| Return | — | 39.68% | -98.45% | -97.52% | -98.85% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 703K | -$ 10M | $ 29K |
| 2024 | $ 849K | $ 11M | $ 187K |
| 2023 | $ 0.00 | -$ 17M | $ 1M |
| 2022 | $ 0.00 | -$ 23M | $ 2M |
| 2021 | $ 0.00 | -$ 24M | $ 22M |
| 2020 | $ 0.00 | -$ 31M | $ 41M |
| 2019 | -$ 366K | -$ 23M | $ 569K |
| 2018 | $ 0.00 | -$ 13M | $ 7M |
| 2017 | $ 0.00 | -$ 4M | $ 7M |
| 2016 | $ 0.00 | -$ 4M | $ 9M |
| 2015 | $ 0.00 | -$ 8M | $ 15M |
| 2014 | $ 0.00 | -$ 9M | $ 8M |
| 2013 | $ 0.00 | -$ 4M | $ 3M |
| 2012 | $ 0.00 | -$ 3M | $ 4M |
| 2011 | $ 0.00 | -$ 3M | $ 1M |
| 2010 | -$ 2M | $ 93K | |
| 2009 | -$ 1M | $ 1K | |
| 2008 | -$ 3M | $ 2K | |
| 2007 | -$ 6M | $ 86K | |
| 2006 | -$ 3M | $ 60K | |
| 2005 | -$ 3M | $ 290.22K | |
| 2004 | -$ 18M | $ 526.52K | |
| IPO2003 | -$ 73.3K | $ 4.6K |
Explore beyond BCLI
You're looking at Brainstorm Cell Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
